The PURA Syndrome Podcast
How do you find one tiny deletion amongst three billion base pairs of DNA? In 2014, PURA Syndrome didn't even exist in medical literature; today, it is a global movement of "citizen scientists" rewriting the rules of neurogenetics. In this episode, we dive into the "diagnostic wilderness" and explore how the PURA Syndrome Foundation has bridged the gap between a shrug of a doctor’s shoulders and a high-speed roadmap to a cure. Whether you are a newly diagnosed family or a long-time advocate, discover how this community is moving the needle from survival to breakthrough. Key Takeaways: * The Power of POPS: Learn how the "Parents of PURA Syndrome" Facebook group acts as a decentralised clinical database, identifying symptoms like sub-clinical seizures months before traditional peer-reviewed journals. * Citizen Science: Understand how parents have evolved into care coordinators and researchers, funding everything from the first "knockout" mouse models to global patient registries. * The Matrix Registry: Discover why logging data at 10:00 PM is the most important thing a parent can do to build the longitudinal "natural history" required for FDA drug approval. * Future Therapeutics: A breakdown of the current roadmap to a cure, including ASOs (Antisense Oligonucleotides), drug repurposing, and the "science fiction" reality of gene replacement therapy. Episode Highlights: (00:00) – The "Broken Arm" analogy: Why neurogenetics breaks the traditional medical framework. (03:52) – 2014 Genesis: Dr David Hunt and the first clinical recognition of PURA Syndrome. (07:22) – Understanding Haploinsufficiency: Why the brain can’t function on 50% protein capacity. (11:05) – The POPS Network: Crowdsourcing clinical data and bypassing the medical "sluggishness." (14:50) – Navigating the UK Legal System: Expert tips on EHCPs and fighting for educational provision. (20:01) – The Matrix Platform: How the Global Patient Registry creates the "control group" for future trials. (24:00) – CRISPR & JAX: The creation of the first PURA Syndrome mouse model. (27:45) – The Therapeutic Roadmap: Exploring ASOs, drug repurposing, and viral vectors for gene therapy. (32:14) – Rare doesn't mean alone: Previewing the 2026 Global Conference in Munich. Support & Resources: For more information, research updates, and community support, visit our official hub at: https://PURASyndrome.app
32 episodes
Comments
0Be the first to comment
Sign up now and become a member of the The PURA Syndrome Podcast community!